TSRL, Inc.

June 17, 2014 10:57 ET

TSRL, Inc. Announces Agreement With Software Licensee

ANN ARBOR, MI--(Marketwired - Jun 17, 2014) - Therapeutic Systems Research Laboratories, (TSRL), Inc. announced today that it has entered into a Termination and Non-Assertion Agreement (the "Agreement") with Simulations Plus, Inc., a California corporation ("SLP"). Under the terms of the Agreement, SLP and TSRL agreed to terminate the Exclusive Software Licensing Agreement, under which TSRL licensed to SLP Software Technology and Databases in return for royalty payments. SLP will pay TSRL a total consideration of $6 million.

TSRL, Inc. is a privately held oral drug delivery specialty firm focused on R&D efforts to enhance the targeted delivery of investigational and marketed therapeutics. More detailed information about TSRL is available on the company website or can be requested by contacting Dr. Elke Lipka, Vice President of Business Development, 734 663-4233 x236,

Contact Information

  • Dr. Elke Lipka
    Vice President of Business Development
    734 663-4233 x236
    Email Contact